| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| MYC |
bone marrow-derived macrophages |
IL4 (10ng/ml) for 2hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0059.1
...
|
| MYC |
bone marrow-derived macrophages |
IL4 (10ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0059.1
...
|
| MYC |
bone marrow-derived macrophages |
IFNg (100 ng/ml) and IL4 (10ng/ml) for 2hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0059.1
...
|
| MYC |
bone marrow-derived macrophages |
IFNg (100 ng/ml) and IL4 (10ng/ml) for 4hrs |
Permissive
Robust
|
Mus musculus |
GSE84518
...
|
MA0059.1
...
|
| MYC |
P493-6 (B-cell lymphoma) |
200 nM OHT (endogenous Myc activated) and 0.2 µg/mL Tetracyclin (Myc transgene repressed) |
Permissive
Robust
|
Homo sapiens |
GSE51004
...
|
MA0059.1
...
|
| MYC |
P493-6 (B-cell lymphoma) |
none (Myc transgene expressed) |
Permissive
Robust
|
Homo sapiens |
GSE51004
...
|
MA0059.1
...
|
| MYC |
NCI-H2171 (small cell lung carcinoma) |
Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC; |
Permissive
Robust
|
Homo sapiens |
GSE112608
...
|
MA0059.1
...
|
| MYC |
HEK293T (embryonic kidney) |
Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; |
Permissive
Robust
|
Homo sapiens |
GSE112608
...
|
MA0059.1
...
|
| MYC |
HEK293T (embryonic kidney) |
Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; |
Permissive
Robust
|
Homo sapiens |
GSE112608
...
|
MA0059.1
...
|
| MYC |
P493-6 (B-cell lymphoma) |
Genotype: scramble shRNA; |
Permissive
|
Homo sapiens |
GSE101853
...
|
MA0059.1
...
|
Showing 10 records in page 368
from 658 pages